| Outcomes | DEX vs. placebo | DEX vs. opioids | Studies | Participants | Effect estimate | Studies | Participants | Effect estimate | MD (OR) and 95% CI | I2 (%) | | MD (OR) and 95% CI | I2 (%) | |
| VAS score (before block) | 2 | 230 | 0.05 [−0.21, 0.31] | 13 | 0.71 | 3 | 318 | −0.12 [−0.40, 0.17] | 17 | 0.41 | VAS score (15 min after block) | 1 | 80 | Not applicable | 1 | 160 | Not applicable | VAS score (30 min after block) | 2 | 230 | −1.56 [−1.81, −1.31] | 30 | <0.00001 | 2 | 158 | −0.20 [−0.58, 0.18] | 0 | 0.31 | VAS score (60 min after block) | 1 | 80 | Not applicable | 2 | 158 | −0.64 [−1.80, 0.52] | 84 | 0.28 | VAS score (120 min after block) | 1 | 74 | Not applicable | 2 | 158 | −0.74 [−1.65, 0.17] | 79 | 0.11 | VAS score (at the moment of disengagement) | 2 | 219 | −0.95 [−1.87, −0.02] | 93 | 0.05 | 1 | 160 | Not applicable | Time of first stage | 5 | 1004 | −12.44 [−34.08, 9.19] | 78 | 0.26 | 3 | 301 | −27.57 [−59.46, 4.33] | 96 | 0.09 | Time of second stage | 5 | 999 | −1.44 [−6.52, 3.64] | 92 | 0.58 | 3 | 301 | 5.62 [−9.92, 21.16] | 99 | 0.48 | Mode of delivery | 3 | 287 | 1.16 [0.44, 3.05] | 0 | 0.77 | 4 | 276 | 1.13 [0.66, 1.93] | 0 | 0.67 | Onset of analgesia | 1 | 60 | Not applicable | 3 | 228 | 0.25 [−2.89, 3.39] | 95 | 0.87 | MAP (before block) | 2 | 230 | 1.89 [−0.83, 4.60] | 0 | 0.17 | 2 | 247 | −0.19 [−2.5, 2.11] | 0 | 0.87 | MAP (15 min after block) | 1 | 80 | Not applicable | 2 | 247 | 1.49 [−7.43, 10.41] | 93 | 0.74 | MAP (30 min after block) | 2 | 230 | −1.16 [−6.35, 4.03] | 75 | 0.66 | 1 | 87 | Not applicable | HR (before the block) | 2 | 230 | −1.33 [−3.19, 0.54] | 0 | 0.16 | 2 | 247 | 1.06 [−1.31, 3.43] | 0 | 0.38 | HR (15 min after block) | 1 | 80 | Not applicable | 2 | 247 | −0.89 [−10.80, 9.02] | 95 | 0.86 | HR (30 min after block) | 2 | 230 | −3.14 [−6.31, 0.04] | 74 | 0.05 | 1 | 87 | Not applicable | Blood loss | 2 | 205 | −6.55 [−13.81, 0.71] | 0 | 0.08 | 1 | 70 | Not applicable | Motor block (modified Bromage scale) | 3 | 785 | Not applicable | 4 | 377 | 0.29 [−0.37, 0.96] | 95 | 0.39 | Apgar score (1 min) | 2 | 207 | 0.01 [−0.08, 0.11] | 0 | 0.79 | 2 | 230 | Not applicable | Apgar score (5 min) | 3 | 357 | 0.00 [−0.07, 0.08] | 0 | 0.89 | 2 | 230 | Not applicable | Umbilical artery pH | 2 | 207 | 0.01 [−0.01, 0.03] | 0 | 0.35 | 3 | 301 | 0.00 [−0.02, 0.02] | 0 | 0.70 | Umbilical artery PaO2 | 0 | | Not applicable | 2 | 230 | 1.25 [−2.88, 5.37] | 96 | 0.55 | Incidence of maternal bradycardia | 4 | 935 | Not applicable | 4 | 388 | 2.90 [1.04, 8.11] | 0 | 0.04 | Incidence of hypotension | 3 | 785 | 1.59 [0.47, 5.36] | 0 | 0.45 | 4 | 388 | 0.68 [0.06, 7.98] | 70 | 0.76 | Incidence of nausea/vomiting | 5 | 1011 | 0.71 [0.37, 1.36] | 0 | 0.30 | 4 | 388 | 0.27 [0.12, 0.61] | 0 | 0.002 | Incidence of itching | 2 | 210 | Not applicable | 4 | 388 | 0.28 [0.07, 1.13] | 2 | 0.07 | Incidence of shivering | 1 | 60 | Not applicable | 2 | 141 | 0.96 [0.26, 3.54] | 0 | 0.95 | Incidence of urinary retention | 2 | 210 | Not applicable | 3 | 301 | 0.49 [0.20, 1.15] | 0 | 0.10 | Incidence of fetal heart rate abnormality | 1 | 147 | Not applicable | 3 | 317 | 1.09 [0.44, 2.70] | 0 | 0.86 |
|
|
DEX, dexmedetomidine; MD, mean difference; OR, odds ratio; CI, confidence interval; VAS, visual analog scale; MAP, mean arterial pressure; HR, heart rate.
|